EUVIMEDEUVIMED entdecken
Crossref

Universal Albumin Drugs‐Cored Spherical Nucleic Acid (ad‐SNA) Platform for Targeted Drug Delivery

Xuan Wang, Linxin Tian, Yuqing Li, Wei Yao, Jiawei Zhu, Huayuan Zhou, Ganghui Chen, Tongkai Chen, Zhuang Liu, Weihong Tan, Yu Yang

Angewandte Chemie International Edition · 2025-05 · 64 (19)

DOI: 10.1002/anie.202421949 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 09.03.2025. Verfasst von Xuan Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Medicine (IMM), Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Renji Hospital, School of Medicine, Shang…. Hauptthemen laut MEDLINE: Drug Delivery Systems, Nucleic Acids, Antineoplastic Agents, Drug Carriers. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, "Clinic Plus" Outstanding Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Albumin‐based drug delivery system, exemplified by FDA‐approved treatments like Abraxane, have demonstrated significant potential in cancer therapy. However, albumin carriers still suffer from poor tumor‐targeting capability, leading to low efficacy and systemic side effects on healthy cells in applications. Here, we report a general method for modification of albumin drugs by aptamer coating shell that are hydrophobically inserted into the albumin surface, for constructing albumin drugs‐cored spherical nucleic acid (adSNA). This adSNA platform allows for the versatile loading of various therapeutic agents, including chemotherapy drugs, polyphenols, cuproptosis inducers, and near‐infrared (NIR) photosensitizers, enabling targeted tumor delivery. Compared with covalent method, the hydrophobic insertion method has been proven to be of greater simplicity, higher aptamer‐grafting efficiency, superior tumor‐targeting capabilities, and comparable stability under physiological conditions. In a proof‐of‐concept study, we delivered NIR‐II photothermal agents and heat shock protein inhibitors for tumor‐specific mild photothermal therapy. Compared to traditional photothermal therapy (PTT), this approach utilizes NIR‐II PTT agents to achieve greater tissue penetration while downregulating heat shock proteins in tumor cells, resulting in precise thermal ablation at lower temperatures. In addition, the adSNAs are straightforward to synthesize and scalable for large‐scale production, offering significant potential to advance the development of clinical targeted drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Delivery SystemsNucleic AcidsAntineoplastic AgentsDrug CarriersAlbuminsHumansAnimalsMicePhotosensitizing AgentsCell Line, Tumor

Stichwörter der Autor:innen

Albumin drugsAptamerLow‐temperature photothermal therapySpherical nucleic acid

Substanzen

Nucleic AcidsAntineoplastic AgentsDrug CarriersAlbuminsPhotosensitizing Agents

Autor:innen und Institutionen

  • Institute of Molecular Medicine (IMM), Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
  • Institute of Functional Nano & Soft Materials (FUNSOM), Soochow University, Suzhou, 215123, China.
  • Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • "Clinic Plus" Outstanding Project
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Wang, X., Tian, L., Li, Y., Yao, W., Zhu, J., Zhou, H., Chen, G., Chen, T., Liu, Z., Tan, W., & Yang, Y. (2025). Universal Albumin Drugs‐Cored Spherical Nucleic Acid (ad‐SNA) Platform for Targeted Drug Delivery. Angewandte Chemie International Edition, 64(19). https://doi.org/10.1002/anie.202421949

Vancouver

Wang X, Tian L, Li Y, Yao W, Zhu J, Zhou H, et al. Universal Albumin Drugs‐Cored Spherical Nucleic Acid (ad‐SNA) Platform for Targeted Drug Delivery. Angewandte Chemie International Edition. 2025;64(19). doi:10.1002/anie.202421949

BibTeX
@article{Wang2025,
  author = {Wang, Xuan and Tian, Linxin and Li, Yuqing and Yao, Wei and Zhu, Jiawei and Zhou, Huayuan and Chen, Ganghui and Chen, Tongkai and Liu, Zhuang and Tan, Weihong and Yang, Yu},
  title = {Universal Albumin Drugs‐Cored Spherical Nucleic Acid (ad‐SNA) Platform for Targeted Drug Delivery},
  journal = {Angewandte Chemie International Edition},
  year = {2025},
  volume = {64},
  number = {19},
  doi = {10.1002/anie.202421949}
}
Kostenlos starten →